Rhumbline Advisers Verrica Pharmaceuticals Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 24,749 shares of VRCA stock, worth $196,754. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,749
Previous 26,591 6.93%
Holding current value
$196,754
Previous $193,000 1.55%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$7.95 - $7.95 $14,643 - $14,643
-1,842 Reduced 6.93%
24,749 $196,000
Q2 2024

Aug 01, 2024
BUY
$5.89 - $9.56 $26,587 - $43,153
4,514 Added 20.45%
26,591 $193,000
Q1 2024

May 09, 2024
SELL
$4.74 - $6.81 $1,474 - $2,117
-311 Reduced 1.39%
22,077 $130,000
Q4 2023

Feb 08, 2024
SELL
$2.93 - $7.32 $3,061 - $7,649
-1,045 Reduced 4.46%
22,388 $163,000
Q3 2023

Nov 09, 2023
BUY
$3.75 - $7.46 $10,931 - $21,745
2,915 Added 14.21%
23,433 $90,000
Q2 2023

Aug 08, 2023
BUY
$5.32 - $6.79 $109,155 - $139,317
20,518 New
20,518 $118,000
Q2 2022

Aug 11, 2022
SELL
$1.81 - $8.93 $23,111 - $114,027
-12,769 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$7.59 - $9.49 $4,394 - $5,494
-579 Reduced 4.34%
12,769 $104,000
Q4 2021

Feb 10, 2022
BUY
$9.1 - $13.36 $3,385 - $4,969
372 Added 2.87%
13,348 $122,000
Q3 2021

Nov 12, 2021
BUY
$9.55 - $13.96 $1,260 - $1,842
132 Added 1.03%
12,976 $162,000
Q2 2021

Aug 05, 2021
SELL
$9.77 - $15.33 $5,764 - $9,044
-590 Reduced 4.39%
12,844 $145,000
Q1 2021

May 06, 2021
SELL
$10.51 - $17.46 $6,936 - $11,523
-660 Reduced 4.68%
13,434 $204,000
Q4 2020

Feb 10, 2021
BUY
$7.41 - $12.63 $6,743 - $11,493
910 Added 6.9%
14,094 $162,000
Q3 2020

Nov 12, 2020
SELL
$6.16 - $10.3 $13,182 - $22,042
-2,140 Reduced 13.97%
13,184 $102,000
Q2 2020

Aug 13, 2020
SELL
$9.02 - $15.12 $18,067 - $30,285
-2,003 Reduced 11.56%
15,324 $169,000
Q1 2020

May 06, 2020
BUY
$7.14 - $16.86 $714 - $1,686
100 Added 0.58%
17,327 $189,000
Q4 2019

Feb 05, 2020
BUY
$13.08 - $17.43 $4,041 - $5,385
309 Added 1.83%
17,227 $274,000
Q3 2019

Oct 23, 2019
BUY
$8.65 - $14.81 $7,767 - $13,299
898 Added 5.61%
16,918 $250,000
Q2 2019

Aug 14, 2019
BUY
$7.1 - $11.62 $40,967 - $67,047
5,770 Added 56.29%
16,020 $186,000
Q1 2019

May 01, 2019
BUY
$7.95 - $14.07 $81,487 - $144,217
10,250 New
10,250 $111,000

Others Institutions Holding VRCA

# of Institutions
78
Shares Held
14.2M
Call Options Held
9.9K
Put Options Held
6.5K
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email